Full Length ArticleIn vitro and in vivo evaluation of 10-Hydroxycamptothecin (cas 19685-09-7)-loaded poly (n-butyl cyanoacrylate) nanoparticles prepared by miniemulsion polymerization
-
Add time:09/07/2019 Source:sciencedirect.com
In this paper, 10-hydroxycamptothecin (HCPT)-loaded poly (n-butyl cyanoacrylate) nanoparticles (HCPT-PBCA-NPs) co-modified with polysorbate 80, soybean phospholipids, and polyethylene glycol (100) monostearate were successfully prepared via miniemulsion polymerization, and were characterized for particle size, morphology, zeta potential, encapsulation efficiency (EE) and drug loading capacity (DL). The chemical structure of HCPT-PBCA-NPs and the state of HCPT in the PBCA-NPs were investigated by DSC, FTIR and 1H NMR. Additionally, drug release, cytotoxicity, cellular uptake capacity, cellular uptake mechanism, and in vivo behavior of NPs were investigated as well. The particles were 92.7 nm in size with a high EE of 94.24%. FTIR, 1H NMR, and DSC demonstrated complete polymerization of BCA monomers and the drug was in a molecular or amorphous form inside the NPs. In vitro release of the drug from HCPT-PBCA-NPs exhibited sustained-release and less than 60% of HCPT was released from the NPs within 24 h of dialysis. Cellular uptake study displayed that Caco-2 cell uptake of NPs was governed by active endocytosis, clathrin- and caveolin-mediated process, and increased with the increase of the NPs concentration and the time. The pharmacokinetic study in rats showed that encapsulation of HCPT into PBCA-NPs increased the Cmax and AUC0−t about 6.52 and 7.56 times, respectively, in comparison with the HCPT suspension. It was concluded that HCPT loaded PBCA-NPs prepared by miniemulsion polymerization could be promising in oral drug delivery.
We also recommend Trading Suppliers and Manufacturers of 10-Hydroxycamptothecin (cas 19685-09-7). Pls Click Website Link as below: cas 19685-09-7 suppliers
Prev:An efficient approach for the enzyme-enhanced extraction of camptothecin and 10-Hydroxycamptothecin (cas 19685-09-7) from the samara of Camptotheca acuminata using an ionic liquid solution
Next:Original articleStudy the voltammetric behavior of 10-Hydroxycamptothecin (cas 19685-09-7) and its sensitive determination at electrochemically reduced graphene oxide modified glassy carbon electrode) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Original articleStudy the voltammetric behavior of 10-Hydroxycamptothecin (cas 19685-09-7) and its sensitive determination at electrochemically reduced graphene oxide modified glassy carbon electrode09/08/2019
- An efficient approach for the enzyme-enhanced extraction of camptothecin and 10-Hydroxycamptothecin (cas 19685-09-7) from the samara of Camptotheca acuminata using an ionic liquid solution09/06/2019
- Review articleAntibody-drug conjugates of 7-ethyl-10-Hydroxycamptothecin (cas 19685-09-7): Sacituzumab govitecan and labetuzumab govitecan09/05/2019
- Incorporation of 10-Hydroxycamptothecin (cas 19685-09-7) nanocrystals into zein microspheres09/04/2019
- Monodisperse oligoethylene glycols modified Camptothecin, 10-Hydroxycamptothecin (cas 19685-09-7) and SN38 prodrugs09/03/2019
- ORIGINAL ARTICLEMenthol-modified casein nanoparticles loading 10-Hydroxycamptothecin (cas 19685-09-7) for glioma targeting therapy09/02/2019
- Full Length ArticleSelf-assembly behavior of amphiphilic poly(ethylene glycol)-conjugated 10-Hydroxycamptothecin (cas 19685-09-7) in water and its cytotoxicity assay09/01/2019
- Enzyme/pH dual-responsive polymer prodrug nanoparticles based on 10-Hydroxycamptothecin (cas 19685-09-7)-carboxymethylchitosan for enhanced drug stability and anticancer efficacy08/31/2019
-
Health and Chemical more >
-
Related Products


